Impact Biomedical (IBO)CFO sold ~$24K

~$24K

Approx. value · 43K sh @ $0.5615

155K

Holds after · shares reported

Traded

Mar 27, 2026

Filed

Mar 31, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Feb 27, 2026Company filing · Form 8-K · Material agreementSigned an important agreement
2. Mar 23, 2026InsiderDirector sold ~$33K of IBO shares in the open market
3. Mar 25, 2026InsiderCFO sold ~$961 of IBO shares in the open market
4. Mar 27, 2026 · this disclosureInsiderCFO sold ~$24K of IBO shares in the open market

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Impact Biomedical

For Impact Biomedical, OQRO holds 3 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its IBO page.

Other recent filings by Todd D Macko, Chief Financial Officer

• SEC Form 4 at Impact Biomedical (IBO)Mar 31, 2026

The full history of Todd D Macko, Chief Financial Officer is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Impact Biomedical

• SEC Form 4Sep 24, 2026
• SEC Form 4Sep 24, 2026
• SEC Form 4Sep 24, 2026
• SEC Form 4Mar 31, 2026
• SEC Form 4Mar 25, 2026
• SEC Form 4Jan 6, 2026

Everything OQRO holds on this company is on its IBO page.